The lab analyst performs a genomic sequence analysis panel to evaluate the patient specimen, such as tumor tissue or bone marrow, for RNA alterations in 51 or more genes known to relate to solid organ cancers or to blood or lymph (hematolymphoid) disorders or cancers.
For clinical responsibility, terminology, tips and additional info
start codify free trial.